RE:RE:Eternal Groundhog DayAs a sidenote, GUD has been buying back shares aggressively and are on pace to maxing out the allotted 8M shares until mid July which would put us at around 107M shares outstanding. 34M of them owned by goodman and Armoyan alone.
One last note on change. The company has now put potential exit dates on the fund investments. Large chunks aiming for 2025-2027 and all by 2030. For those who are patient (maybe extremely patient) what will the company look like then?
I think they will have moved into another geographic area by then and likely bolstered their Latam (mexico) region while growing exisitng platform. I would think the market would much prefer a pure play pharma company. What will our shares oustanding be by then?
So where could that leave us? I think it could be multiples higher than 5$/share